Partnering for Progress: Leveraging Advocacy Groups to Drive Awareness and Participation in IPF Trials
John Hood, CEO, Endeavor BioMedicines discusses partnering with advocacy groups to increase awareness of clinical trials for idiopathic pulmonary fibrosis.


